Company intelligence / Profile preview

Galmed Pharmaceuticals

Ramat Gan / Tel Aviv, Tel Aviv District, Israelgalmedpharma.com ↗
Ownership
Public · GLMD
Employees
~6
Development stage
Phase 3
01

Overview

Galmed’s lead compound Aramchol has shown promising results in reducing markers of systemic inflammation and liver fibrosis in NASH patients. The company recently unveiled novel pharmacodynamic blood markers that may serve as early indicators of efficacy. Clinical trial data have driven recent market optimism and strategic partnerships with research hospitals. The company’s financials show improved liquidity but ongoing need for capital

Therapeutic areas
GastroenterologyCardiovascularImmunologyOncologyInfectious Diseases
Modalities
small molecules (notably synthetic fatty acid-bile acid conjugates)peptides
Industry
Biotech
02

Drug pipeline

3 assets

aramchol

3

2 more assets in the full pipeline.

03

Partnerships

Samil Pharma Co., Ltd. (commercialization of Aramchol in South Korea)OnKai (AI platform collaboration)Proteas Health (biomarker assay development)

Beyond the preview

Go deeper on Galmed Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galmed Pharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call